+

PE20030327A1 - 3-5-dihidroxi-2,2-dimetil-valeronitrilos protegidos para la sintesis de epotilonas y sus derivados y metodo para su obtencion - Google Patents

3-5-dihidroxi-2,2-dimetil-valeronitrilos protegidos para la sintesis de epotilonas y sus derivados y metodo para su obtencion

Info

Publication number
PE20030327A1
PE20030327A1 PE2002000703A PE2002000703A PE20030327A1 PE 20030327 A1 PE20030327 A1 PE 20030327A1 PE 2002000703 A PE2002000703 A PE 2002000703A PE 2002000703 A PE2002000703 A PE 2002000703A PE 20030327 A1 PE20030327 A1 PE 20030327A1
Authority
PE
Peru
Prior art keywords
dimethyl
pentan
nitrile
epotilones
dihydroxy
Prior art date
Application number
PE2002000703A
Other languages
English (en)
Inventor
Jurgen Westermann
Johann Platzek
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20030327A1 publication Critical patent/PE20030327A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/16—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same carbon atom of an acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C12P13/004—Cyanohydrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/12—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/13—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C07C255/20—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SE REFIERE A SINTESIS DE EPOTILONAS MODIFICADAS DE FORMULA I Y DE ANTIPODAS DONDE R1 Y R2 SON BENCILO, 4-METOXIBENCILO, 3,4-DIMETOXIBENCILO, ALILO, TRITILO, O SI FORMAN UN PUENTE SON UN GRUPO DE PROTECCION CETAL COMO GRUPO a, b, c, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 2,2-DIMETIL-3,5-DIHIDROXI-VALERONITRILO; 3(S)-3,5-ACETONDIMETILACETAL-2,2-DIMETIL-PENTAN-NITRILO; 3(S)-3,5-BENZALDEHIDO-DIMETILACETAL-2,2-DIMETIL-PENTAN-NITRILO; 3(S)-3,5-DITERBUTILDIMETILSILILOXI-2,2-DIMETIL-PENTAN-NITRILO; 3,5-BENZALDEHIDO-DIMETILACETAL-2,2-DIMETIL-PENTAN-NITRILO; 3,5-DIFENILSILAN-2,2-DIMETIL-PENTAN-NITRILO, ENTRE OTROS. TAMBIEN SE REFIERE A UN METODO PARA OBTENER CETONAS DE FORMULA A, V ES ALQUILO C1-C5, ALQUENILO. LOS COMPUESTOS SON MACROLIDOS DE 16 CARBONOS ANTITUMORALES DE PUREZA ENANTIOMERICA, QUIMICA, BUEN RENDIMIENTO
PE2002000703A 2001-08-03 2002-08-02 3-5-dihidroxi-2,2-dimetil-valeronitrilos protegidos para la sintesis de epotilonas y sus derivados y metodo para su obtencion PE20030327A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10138347A DE10138347A1 (de) 2001-08-03 2001-08-03 Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeronitrile für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
PE20030327A1 true PE20030327A1 (es) 2003-04-10

Family

ID=7694414

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000703A PE20030327A1 (es) 2001-08-03 2002-08-02 3-5-dihidroxi-2,2-dimetil-valeronitrilos protegidos para la sintesis de epotilonas y sus derivados y metodo para su obtencion

Country Status (21)

Country Link
US (2) US7034165B2 (es)
EP (1) EP1412323B1 (es)
JP (1) JP4620346B2 (es)
KR (1) KR100876036B1 (es)
CN (1) CN100482641C (es)
AR (1) AR036206A1 (es)
AT (1) ATE444283T1 (es)
AU (1) AU2002333336B2 (es)
BR (1) BR0211651A (es)
CA (1) CA2455797C (es)
DE (2) DE10138347A1 (es)
ES (1) ES2331468T3 (es)
HK (1) HK1070350A1 (es)
IL (1) IL159726A0 (es)
MX (1) MXPA04001060A (es)
NO (1) NO20040911L (es)
PE (1) PE20030327A1 (es)
PL (1) PL367429A1 (es)
RU (1) RU2303590C2 (es)
WO (1) WO2003014068A1 (es)
ZA (1) ZA200401722B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6204388B1 (en) * 1996-12-03 2001-03-20 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
JP4579351B2 (ja) 1996-12-03 2010-11-10 スローン−ケッタリング インスティトュート フォア キャンサー リサーチ エポチロンの合成とその中間体及びその類似物並びにその使用
US7368568B2 (en) * 2001-08-03 2008-05-06 Bayer Schering Pharma Ag Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use
WO2003029195A1 (fr) 2001-09-28 2003-04-10 Sumika Fine Chemicals Co., Ltd. Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
CN1759115A (zh) 2002-08-23 2006-04-12 索隆-基特林癌症研究协会 埃坡霉素(epothilone),合成埃坡霉素的中间体,其类似物及其用途
US6921769B2 (en) 2002-08-23 2005-07-26 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
EP2634252B1 (en) 2005-02-11 2018-12-19 University of Southern California Method of expressing proteins with disulfide bridges
EP2029156A4 (en) * 2006-05-01 2010-07-21 Univ Southern California COMBINATION THERAPY FOR CANCER TREATMENT
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1196698C (zh) * 1996-11-18 2005-04-13 生物技术研究有限公司(Gbf) Epothilone D、E和F,其制备方法,以及作为细胞抑制剂和植物保护剂的应用
DE19701758A1 (de) * 1997-01-20 1998-07-23 Wessjohann Ludgar A Dr Epothilone-Synthesebausteine
US6603015B2 (en) * 1999-03-29 2003-08-05 University Of Kansas Synthesis of epothilones
US6211412B1 (en) * 1999-03-29 2001-04-03 The University Of Kansas Synthesis of epothilones
WO2003029195A1 (fr) * 2001-09-28 2003-04-10 Sumika Fine Chemicals Co., Ltd. Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production

Also Published As

Publication number Publication date
ZA200401722B (en) 2004-10-08
KR100876036B1 (ko) 2008-12-26
US7034165B2 (en) 2006-04-25
ATE444283T1 (de) 2009-10-15
JP4620346B2 (ja) 2011-01-26
AU2002333336B2 (en) 2008-05-29
DE50213889D1 (de) 2009-11-12
CN100482641C (zh) 2009-04-29
KR20040022229A (ko) 2004-03-11
US7358382B2 (en) 2008-04-15
DE10138347A1 (de) 2003-02-27
HK1070350A1 (en) 2005-06-17
CA2455797A1 (en) 2003-02-20
BR0211651A (pt) 2004-07-13
MXPA04001060A (es) 2004-05-20
JP2004537591A (ja) 2004-12-16
US20030149281A1 (en) 2003-08-07
IL159726A0 (en) 2004-06-20
AR036206A1 (es) 2004-08-18
PL367429A1 (en) 2005-02-21
CN1538954A (zh) 2004-10-20
EP1412323A1 (de) 2004-04-28
RU2303590C2 (ru) 2007-07-27
EP1412323B1 (de) 2009-09-30
WO2003014068A1 (de) 2003-02-20
US20050267306A1 (en) 2005-12-01
RU2004106532A (ru) 2005-07-27
NO20040911L (no) 2004-03-02
ES2331468T3 (es) 2010-01-05
CA2455797C (en) 2010-11-16

Similar Documents

Publication Publication Date Title
DK1117648T3 (da) Tetrahydroquinolinderivater med selektiv virkning for retinoid X receptorer
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
CO5690638A2 (es) Nuevos compuestos triciclicos utiles para el tratamiento de desordenes inflamatorios y alergicos; proceso para su preparacion y composiciones farmaceuticas que los contienen
PE20040644A1 (es) Nuevos derivados de quinuclidina-amina
AR034734A1 (es) Sintesis e intermediarios
PE20030327A1 (es) 3-5-dihidroxi-2,2-dimetil-valeronitrilos protegidos para la sintesis de epotilonas y sus derivados y metodo para su obtencion
AR036659A1 (es) Compuestos derivados de fenil-piperazina, fenil-piperidina y fenil-tetrahidropiridina como inhibidores de la reabsorcion de la serotonina, una composicion farmaceutica y utilizacion de los mismos para la preparacion de medicamentos
AR016429A1 (es) Compuesto derivado de acido hidroxamico como inhibidores de metaloproteasa de matriz (mmp), composiciones farmaceuticas y formulaciones veterinarias, usopara la preparacion de composiciones y formulaciones, compuesto intermediario, procedimiento de preparacion del compuesto.
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
AR061371A1 (es) Amino - imidazolonas y su uso como medicamento para la enfermedad de alzheimer y otras enfermedades neurodegenerativas.
AR044400A1 (es) Procesos para la preparacion de derivados de pirimidina
ATE252575T1 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
DE69918465D1 (de) Sulfonamidhydroxamate
RS52161B (en) NEW CRYSTAL POLYMORPHIC FORMS OF LERCANIDIPINE HYDROCHLORIDE AND A PROCEDURE FOR OBTAINING THEM
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
ES2106936T3 (es) Derivados de carbazolona y procedimientos para su preparacion.
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
HUP9902199A1 (hu) Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
NO20022977D0 (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
DK1102765T3 (da) Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater
PE20030345A1 (es) 3,5-dihidroxi-2,2-dimetil-valeroamidas protegidas para la sintesis de epotilonas y derivados y un procedimiento para su preparacion
AR028685A1 (es) Derivados de indol

Legal Events

Date Code Title Description
FC Refusal
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载